 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Complex (transcription activator/DNA)
|
PDB id
|
|
|
|
1mhd
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
intracellular
|
2 terms
|
 |
|
Biological process
|
regulation of transcription, DNA-dependent
|
2 terms
|
 |
|
Biochemical function
|
protein binding
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
94:585-594
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling.
|
|
Y.Shi,
Y.F.Wang,
L.Jayaraman,
H.Yang,
J.Massagué,
N.P.Pavletich.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Smad family of proteins, which are frequently targeted by tumorigenic
mutations in cancer, mediate TGF-beta signaling from cell membrane to nucleus.
The crystal structure of a Smad3 MH1 domain bound to an optimal DNA sequence
determined at 2.8 A resolution reveals a novel DNA-binding motif. In the
crystals, base-specific DNA recognition is provided exclusively by a conserved
11-residue beta hairpin that is embedded in the major groove of DNA. A surface
loop region, to which tumorigenic mutations map, has been identified as a
functional surface important for Smad activity. This structure establishes a
framework for understanding how Smad proteins may act in concert with other
transcription factors in the regulation of TGF-beta-responsive genes.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Figure 5. Identification of Functional Regions by Sequence
Conservation, Solvent Accessibility, and Tumorigenic
Mutations(A) Mapping of the tumorigenic mutations, the invariant
and solvent-exposed residues, identifies the β hairpin, the
L2/L4 double loop, and the H2 basic helix as regions likely to
be important for Smad functions. Color coding is the same as in
Figure 2. Residues at which tumor-derived mutations occur are
labeled, with corresponding mutations indicated in
parentheses.(B) Close-up view showing the region with four
tumorigenic mutations. Surrounding residues, which the
tumorigenic residues pack against, are shown in purple.
|
 |
Figure 6.
Figure 6. Comparison of DNA Recognition by β Hairpin to
Known Protein–DNA Interactions that Involve β SheetsThe β
hairpin of MH1 domain bound to Smad box, together with the MetJ
([35]) and Arc ( [30]) repressor–operator complexes, are
schematically represented with DNA sequences and the DNA-binding
motifs. Hydrogen bonds between β strand side chains and DNA
bases are indicated by arrows.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(1998,
94,
585-594)
copyright 1998.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.Meulmeester,
and
P.Ten Dijke
(2011).
The dynamic roles of TGF-β in cancer.
|
| |
J Pathol, 223,
205-218.
|
 |
|
|
|
|
 |
A.Atfi,
and
R.Baron
(2010).
PTH battles TGF-beta in bone.
|
| |
Nat Cell Biol, 12,
205-207.
|
 |
|
|
|
|
 |
A.Weiss,
E.Charbonnier,
E.Ellertsdóttir,
A.Tsirigos,
C.Wolf,
R.Schuh,
G.Pyrowolakis,
and
M.Affolter
(2010).
A conserved activation element in BMP signaling during Drosophila development.
|
| |
Nat Struct Mol Biol, 17,
69-76.
|
 |
|
|
|
|
 |
J.P.Burke,
R.W.Watson,
J.J.Mulsow,
N.G.Docherty,
J.C.Coffey,
and
P.R.O'Connell
(2010).
Endoglin negatively regulates transforming growth factor beta1-induced profibrotic responses in intestinal fibroblasts.
|
| |
Br J Surg, 97,
892-901.
|
 |
|
|
|
|
 |
K.Miyazono,
Y.Kamiya,
and
M.Morikawa
(2010).
Bone morphogenetic protein receptors and signal transduction.
|
| |
J Biochem, 147,
35-51.
|
 |
|
|
|
|
 |
M.Mimeault,
and
S.K.Batra
(2010).
Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.
|
| |
J Cell Physiol, 224,
626-635.
|
 |
|
|
|
|
 |
N.BabuRajendran,
P.Palasingam,
K.Narasimhan,
W.Sun,
S.Prabhakar,
R.Jauch,
and
P.R.Kolatkar
(2010).
Structure of Smad1 MH1/DNA complex reveals distinctive rearrangements of BMP and TGF-beta effectors.
|
| |
Nucleic Acids Res, 38,
3477-3488.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Lönn,
L.P.van der Heide,
M.Dahl,
U.Hellman,
C.H.Heldin,
and
A.Moustakas
(2010).
PARP-1 attenuates Smad-mediated transcription.
|
| |
Mol Cell, 40,
521-532.
|
 |
|
|
|
|
 |
R.Bergström,
K.Savary,
A.Morén,
S.Guibert,
C.H.Heldin,
R.Ohlsson,
and
A.Moustakas
(2010).
Transforming growth factor beta promotes complexes between Smad proteins and the CCCTC-binding factor on the H19 imprinting control region chromatin.
|
| |
J Biol Chem, 285,
19727-19737.
|
 |
|
|
|
|
 |
S.Rajanahally,
J.E.Agno,
R.L.Nalam,
M.B.Weinstein,
K.L.Loveland,
M.M.Matzuk,
and
Q.Li
(2010).
Genetic evidence that SMAD2 is not required for gonadal tumor development in inhibin-deficient mice.
|
| |
Reprod Biol Endocrinol, 8,
69.
|
 |
|
|
|
|
 |
S.Tao,
and
K.Sampath
(2010).
Alternative splicing of SMADs in differentiation and tissue homeostasis.
|
| |
Dev Growth Differ, 52,
335-342.
|
 |
|
|
|
|
 |
T.Qiu,
X.Wu,
F.Zhang,
T.L.Clemens,
M.Wan,
and
X.Cao
(2010).
TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.
|
| |
Nat Cell Biol, 12,
224-234.
|
 |
|
|
|
|
 |
V.G.Thackray,
P.L.Mellon,
and
D.Coss
(2010).
Hormones in synergy: regulation of the pituitary gonadotropin genes.
|
| |
Mol Cell Endocrinol, 314,
192-203.
|
 |
|
|
|
|
 |
C.Millet,
M.Yamashita,
M.Heller,
L.R.Yu,
T.D.Veenstra,
and
Y.E.Zhang
(2009).
A negative feedback control of transforming growth factor-beta signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204.
|
| |
J Biol Chem, 284,
19808-19816.
|
 |
|
|
|
|
 |
F.Chaverneff,
and
J.Barrett
(2009).
Casein kinase II contributes to the synergistic effects of BMP7 and BDNF on Smad 1/5/8 phosphorylation in septal neurons under hypoglycemic stress.
|
| |
J Neurochem, 109,
733-743.
|
 |
|
|
|
|
 |
I.L.Blitz,
and
K.W.Cho
(2009).
Finding partners: How BMPs select their targets.
|
| |
Dev Dyn, 238,
1321-1331.
|
 |
|
|
|
|
 |
J.Heger,
S.C.Peters,
H.M.Piper,
and
G.Euler
(2009).
SMAD-proteins as a molecular switch from hypertrophy to apoptosis induction in adult ventricular cardiomyocytes.
|
| |
J Cell Physiol, 220,
515-523.
|
 |
|
|
|
|
 |
P.Kahlem,
and
S.J.Newfeld
(2009).
Informatics approaches to understanding TGFbeta pathway regulation.
|
| |
Development, 136,
3729-3740.
|
 |
|
|
|
|
 |
P.Sysa,
J.J.Potter,
X.Liu,
and
E.Mezey
(2009).
Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors.
|
| |
DNA Cell Biol, 28,
425-434.
|
 |
|
|
|
|
 |
W.Gao,
H.Zhu,
J.Y.Zhang,
and
X.J.Zhang
(2009).
Calcium signaling-induced Smad3 nuclear accumulation induces acetylcholinesterase transcription in apoptotic HeLa cells.
|
| |
Cell Mol Life Sci, 66,
2181-2193.
|
 |
|
|
|
|
 |
Y.L.Chen,
B.Liu,
Z.N.Zhou,
R.Y.Hu,
C.Fei,
Z.H.Xie,
and
X.Ding
(2009).
Smad6 inhibits the transcriptional activity of Tbx6 by mediating its degradation.
|
| |
J Biol Chem, 284,
23481-23490.
|
 |
|
|
|
|
 |
B.N.Davis,
A.C.Hilyard,
G.Lagna,
and
A.Hata
(2008).
SMAD proteins control DROSHA-mediated microRNA maturation.
|
| |
Nature, 454,
56-61.
|
 |
|
|
|
|
 |
C.E.Konikoff,
R.G.Wisotzkey,
and
S.J.Newfeld
(2008).
Lysine conservation and context in TGFbeta and Wnt signaling suggest new targets and general themes for posttranslational modification.
|
| |
J Mol Evol, 67,
323-333.
|
 |
|
|
|
|
 |
J.R.Abend,
and
M.J.Imperiale
(2008).
Transforming growth factor-beta-mediated regulation of BK virus gene expression.
|
| |
Virology, 378,
6.
|
 |
|
|
|
|
 |
L.Aigner,
and
U.Bogdahn
(2008).
TGF-beta in neural stem cells and in tumors of the central nervous system.
|
| |
Cell Tissue Res, 331,
225-241.
|
 |
|
|
|
|
 |
L.Vardouli,
E.Vasilaki,
E.Papadimitriou,
D.Kardassis,
and
C.Stournaras
(2008).
A novel mechanism of TGFbeta-induced actin reorganization mediated by Smad proteins and Rho GTPases.
|
| |
FEBS J, 275,
4074-4087.
|
 |
|
|
|
|
 |
Q.Xi,
W.He,
X.H.Zhang,
H.V.Le,
and
J.Massagué
(2008).
Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program.
|
| |
J Biol Chem, 283,
1146-1155.
|
 |
|
|
|
|
 |
R.H.Xu,
T.L.Sampsell-Barron,
F.Gu,
S.Root,
R.M.Peck,
G.Pan,
J.Yu,
J.Antosiewicz-Bourget,
S.Tian,
R.Stewart,
and
J.A.Thomson
(2008).
NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs.
|
| |
Cell Stem Cell, 3,
196-206.
|
 |
|
|
|
|
 |
R.Hao,
L.Chen,
J.W.Wu,
and
Z.X.Wang
(2008).
Structure of Drosophila Mad MH2 domain.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 64,
986-990.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Hariharan,
and
M.R.Pillai
(2008).
Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
|
| |
Proteins, 71,
1853-1862.
|
 |
|
|
|
|
 |
S.Ross,
and
C.S.Hill
(2008).
How the Smads regulate transcription.
|
| |
Int J Biochem Cell Biol, 40,
383-408.
|
 |
|
|
|
|
 |
X.Guo,
A.Ramirez,
D.S.Waddell,
Z.Li,
X.Liu,
and
X.F.Wang
(2008).
Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling.
|
| |
Genes Dev, 22,
106-120.
|
 |
|
|
|
|
 |
X.Guo,
D.S.Waddell,
W.Wang,
Z.Wang,
N.T.Liberati,
S.Yong,
X.Liu,
and
X.F.Wang
(2008).
Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.
|
| |
Oncogene, 27,
7235-7247.
|
 |
|
|
|
|
 |
Y.Y.Wan,
and
R.A.Flavell
(2008).
Tgf-Beta and regulatory T cell in immunity and autoimmunity.
|
| |
J Clin Immunol, 28,
647-659.
|
 |
|
|
|
|
 |
A.W.Tu,
and
K.Luo
(2007).
Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response.
|
| |
J Biol Chem, 282,
21187-21196.
|
 |
|
|
|
|
 |
B.Schmierer,
and
C.S.Hill
(2007).
TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility.
|
| |
Nat Rev Mol Cell Biol, 8,
970-982.
|
 |
|
|
|
|
 |
C.Millet,
and
Y.E.Zhang
(2007).
Roles of Smad3 in TGF-beta signaling during carcinogenesis.
|
| |
Crit Rev Eukaryot Gene Expr, 17,
281-293.
|
 |
|
|
|
|
 |
F.Spyrakis,
P.Cozzini,
C.Bertoli,
A.Marabotti,
G.E.Kellogg,
and
A.Mozzarelli
(2007).
Energetics of the protein-DNA-water interaction.
|
| |
BMC Struct Biol, 7,
4.
|
 |
|
|
|
|
 |
K.A.Brown,
J.A.Pietenpol,
and
H.L.Moses
(2007).
A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
|
| |
J Cell Biochem, 101,
9.
|
 |
|
|
|
|
 |
P.T.Loverde,
A.Osman,
and
A.Hinck
(2007).
Schistosoma mansoni: TGF-beta signaling pathways.
|
| |
Exp Parasitol, 117,
304-317.
|
 |
|
|
|
|
 |
R.A.Rahimi,
and
E.B.Leof
(2007).
TGF-beta signaling: a tale of two responses.
|
| |
J Cell Biochem, 102,
593-608.
|
 |
|
|
|
|
 |
S.M.McGillivray,
V.G.Thackray,
D.Coss,
and
P.L.Mellon
(2007).
Activin and glucocorticoids synergistically activate follicle-stimulating hormone beta-subunit gene expression in the immortalized LbetaT2 gonadotrope cell line.
|
| |
Endocrinology, 148,
762-773.
|
 |
|
|
|
|
 |
S.Zhang,
T.Fei,
L.Zhang,
R.Zhang,
F.Chen,
Y.Ning,
Y.Han,
X.H.Feng,
A.Meng,
and
Y.G.Chen
(2007).
Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
|
| |
Mol Cell Biol, 27,
4488-4499.
|
 |
|
|
|
|
 |
T.F.Lerch,
M.Xu,
T.S.Jardetzky,
K.E.Mayo,
I.Radhakrishnan,
R.Kazer,
L.D.Shea,
and
T.K.Woodruff
(2007).
The structures that underlie normal reproductive function.
|
| |
Mol Cell Endocrinol, 267,
1-5.
|
 |
|
|
|
|
 |
T.Grocott,
V.Frost,
M.Maillard,
T.Johansen,
G.N.Wheeler,
L.J.Dawes,
I.M.Wormstone,
and
A.Chantry
(2007).
The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter.
|
| |
Nucleic Acids Res, 35,
890-901.
|
 |
|
|
|
|
 |
Y.Y.Wan,
and
R.A.Flavell
(2007).
'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation.
|
| |
Immunol Rev, 220,
199-213.
|
 |
|
|
|
|
 |
G.Liu,
W.Ding,
J.Neiman,
and
K.M.Mulder
(2006).
Requirement of Smad3 and CREB-1 in mediating transforming growth factor-beta (TGF beta) induction of TGF beta 3 secretion.
|
| |
J Biol Chem, 281,
29479-29490.
|
 |
|
|
|
|
 |
M.O.Li,
Y.Y.Wan,
S.Sanjabi,
A.K.Robertson,
and
R.A.Flavell
(2006).
Transforming growth factor-beta regulation of immune responses.
|
| |
Annu Rev Immunol, 24,
99.
|
 |
|
|
|
|
 |
N.Ghosh-Choudhury,
P.K.Singha,
K.Woodruff,
P.St Clair,
S.Bsoul,
S.L.Werner,
and
G.G.Choudhury
(2006).
Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression.
|
| |
J Biol Chem, 281,
20160-20170.
|
 |
|
|
|
|
 |
P.W.Sanders
(2006).
Effect of salt intake on progression of chronic kidney disease.
|
| |
Curr Opin Nephrol Hypertens, 15,
54-60.
|
 |
|
|
|
|
 |
Q.Jiang,
Y.Matsuzaki,
K.Li,
and
J.Uitto
(2006).
Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene.
|
| |
J Invest Dermatol, 126,
325-335.
|
 |
|
|
|
|
 |
S.Caputo,
J.Couprie,
I.Duband-Goulet,
E.Kondé,
F.Lin,
S.Braud,
M.Gondry,
B.Gilquin,
H.J.Worman,
and
S.Zinn-Justin
(2006).
The carboxyl-terminal nucleoplasmic region of MAN1 exhibits a DNA binding winged helix domain.
|
| |
J Biol Chem, 281,
18208-18215.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Gao,
and
A.Laughon
(2006).
Decapentaplegic-responsive silencers contain overlapping mad-binding sites.
|
| |
J Biol Chem, 281,
25781-25790.
|
 |
|
|
|
|
 |
T.A.Melhuish,
and
D.Wotton
(2006).
The Tgif2 gene contains a retained intron within the coding sequence.
|
| |
BMC Mol Biol, 7,
2.
|
 |
|
|
|
|
 |
X.Zheng,
C.T.Zugates,
Z.Lu,
L.Shi,
J.M.Bai,
and
T.Lee
(2006).
Baboon/dSmad2 TGF-beta signaling is required during late larval stage for development of adult-specific neurons.
|
| |
EMBO J, 25,
615-627.
|
 |
|
|
|
|
 |
Y.Y.Wan,
and
R.A.Flavell
(2006).
The roles for cytokines in the generation and maintenance of regulatory T cells.
|
| |
Immunol Rev, 212,
114-130.
|
 |
|
|
|
|
 |
H.B.Chen,
J.G.Rud,
K.Lin,
and
L.Xu
(2005).
Nuclear targeting of transforming growth factor-beta-activated Smad complexes.
|
| |
J Biol Chem, 280,
21329-21336.
|
 |
|
|
|
|
 |
H.Wang,
K.Song,
T.L.Sponseller,
and
D.Danielpour
(2005).
Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling.
|
| |
J Biol Chem, 280,
5154-5162.
|
 |
|
|
|
|
 |
N.R.Dunn,
C.H.Koonce,
D.C.Anderson,
A.Islam,
E.K.Bikoff,
and
E.J.Robertson
(2005).
Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile.
|
| |
Genes Dev, 19,
152-163.
|
 |
|
|
|
|
 |
N.Safwat,
J.Ninomiya-Tsuji,
A.J.Gore,
and
W.L.Miller
(2005).
Transforming growth factor beta-activated kinase 1 is a key mediator of ovine follicle-stimulating hormone beta-subunit expression.
|
| |
Endocrinology, 146,
4814-4824.
|
 |
|
|
|
|
 |
Q.Zhu,
S.Pearson-White,
and
K.Luo
(2005).
Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
|
| |
Mol Cell Biol, 25,
10731-10744.
|
 |
|
|
|
|
 |
S.Gao,
J.Steffen,
and
A.Laughon
(2005).
Dpp-responsive silencers are bound by a trimeric Mad-Medea complex.
|
| |
J Biol Chem, 280,
36158-36164.
|
 |
|
|
|
|
 |
T.E.Callis,
D.Cao,
and
D.Z.Wang
(2005).
Bone morphogenetic protein signaling modulates myocardin transactivation of cardiac genes.
|
| |
Circ Res, 97,
992.
|
 |
|
|
|
|
 |
T.F.Li,
R.J.O'Keefe,
and
D.Chen
(2005).
TGF-beta signaling in chondrocytes.
|
| |
Front Biosci, 10,
681-688.
|
 |
|
|
|
|
 |
T.Furumatsu,
M.Tsuda,
N.Taniguchi,
Y.Tajima,
and
H.Asahara
(2005).
Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment.
|
| |
J Biol Chem, 280,
8343-8350.
|
 |
|
|
|
|
 |
T.Oren,
I.Torregroza,
and
T.Evans
(2005).
An Oct-1 binding site mediates activation of the gata2 promoter by BMP signaling.
|
| |
Nucleic Acids Res, 33,
4357-4367.
|
 |
|
|
|
|
 |
V.Prokova,
S.Mavridou,
P.Papakosta,
and
D.Kardassis
(2005).
Characterization of a novel transcriptionally active domain in the transforming growth factor beta-regulated Smad3 protein.
|
| |
Nucleic Acids Res, 33,
3708-3721.
|
 |
|
|
|
|
 |
X.H.Feng,
and
R.Derynck
(2005).
Specificity and versatility in tgf-beta signaling through Smads.
|
| |
Annu Rev Cell Dev Biol, 21,
659-693.
|
 |
|
|
|
|
 |
A.M.Heegaard,
Z.Xie,
M.F.Young,
and
K.L.Nielsen
(2004).
Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
|
| |
J Cell Biochem, 93,
463-475.
|
 |
|
|
|
|
 |
A.Osman,
E.G.Niles,
and
P.T.LoVerde
(2004).
Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation.
|
| |
J Biol Chem, 279,
6474-6486.
|
 |
|
|
|
|
 |
E.Karaulanov,
W.Knöchel,
and
C.Niehrs
(2004).
Transcriptional regulation of BMP4 synexpression in transgenic Xenopus.
|
| |
EMBO J, 23,
844-856.
|
 |
|
|
|
|
 |
H.J.Lee,
J.K.Lee,
S.Miyake,
and
S.J.Kim
(2004).
A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes.
|
| |
J Biol Chem, 279,
2666-2672.
|
 |
|
|
|
|
 |
J.P.Frederick,
N.T.Liberati,
D.S.Waddell,
Y.Shi,
and
X.F.Wang
(2004).
Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element.
|
| |
Mol Cell Biol, 24,
2546-2559.
|
 |
|
|
|
|
 |
K.Aurrekoetxea-Hernández,
and
E.Buetti
(2004).
Transforming growth factor beta enhances the glucocorticoid response of the mouse mammary tumor virus promoter through Smad and GA-binding proteins.
|
| |
J Virol, 78,
2201-2211.
|
 |
|
|
|
|
 |
K.Seki,
and
A.Hata
(2004).
Indian hedgehog gene is a target of the bone morphogenetic protein signaling pathway.
|
| |
J Biol Chem, 279,
18544-18549.
|
 |
|
|
|
|
 |
M.J.Calonge,
J.Seoane,
and
J.Massagué
(2004).
Opposite Smad and chicken ovalbumin upstream promoter transcription factor inputs in the regulation of the collagen VII gene promoter by transforming growth factor-beta.
|
| |
J Biol Chem, 279,
23759-23765.
|
 |
|
|
|
|
 |
N.Selvamurugan,
S.Kwok,
and
N.C.Partridge
(2004).
Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells.
|
| |
J Biol Chem, 279,
27764-27773.
|
 |
|
|
|
|
 |
S.Atanasoski,
L.Notterpek,
H.Y.Lee,
F.Castagner,
P.Young,
M.U.Ehrengruber,
D.Meijer,
L.Sommer,
E.Stavnezer,
C.Colmenares,
and
U.Suter
(2004).
The protooncogene Ski controls Schwann cell proliferation and myelination.
|
| |
Neuron, 43,
499-511.
|
 |
|
|
|
|
 |
A.A.Postigo
(2003).
Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway.
|
| |
EMBO J, 22,
2443-2452.
|
 |
|
|
|
|
 |
A.V.Grinberg,
and
T.Kerppola
(2003).
Both Max and TFE3 cooperate with Smad proteins to bind the plasminogen activator inhibitor-1 promoter, but they have opposite effects on transcriptional activity.
|
| |
J Biol Chem, 278,
11227-11236.
|
 |
|
|
|
|
 |
F.Verrecchia,
C.Tacheau,
E.F.Wagner,
and
A.Mauviel
(2003).
A central role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression.
|
| |
J Biol Chem, 278,
1585-1593.
|
 |
|
|
|
|
 |
H.Benchabane,
and
J.L.Wrana
(2003).
GATA- and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations.
|
| |
Mol Cell Biol, 23,
6646-6661.
|
 |
|
|
|
|
 |
H.Jono,
H.Xu,
H.Kai,
D.J.Lim,
Y.S.Kim,
X.H.Feng,
and
J.D.Li
(2003).
Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK.
|
| |
J Biol Chem, 278,
27811-27819.
|
 |
|
|
|
|
 |
J.Chai,
J.W.Wu,
N.Yan,
J.Massagué,
N.P.Pavletich,
and
Y.Shi
(2003).
Features of a Smad3 MH1-DNA complex. Roles of water and zinc in DNA binding.
|
| |
J Biol Chem, 278,
20327-20331.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Harada,
K.Kokura,
C.Kanei-Ishii,
T.Nomura,
M.M.Khan,
Y.Kim,
and
S.Ishii
(2003).
Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
|
| |
J Biol Chem, 278,
38998-39005.
|
 |
|
|
|
|
 |
J.Long,
I.Matsuura,
D.He,
G.Wang,
K.Shuai,
and
F.Liu
(2003).
Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.
|
| |
Proc Natl Acad Sci U S A, 100,
9791-9796.
|
 |
|
|
|
|
 |
K.Ogawa,
F.Chen,
Y.J.Kim,
and
Y.Chen
(2003).
Transcriptional regulation of tristetraprolin by transforming growth factor-beta in human T cells.
|
| |
J Biol Chem, 278,
30373-30381.
|
 |
|
|
|
|
 |
R.Serra,
and
C.Chang
(2003).
TGF-beta signaling in human skeletal and patterning disorders.
|
| |
Birth Defects Res C Embryo Today, 69,
333-351.
|
 |
|
|
|
|
 |
S.M.Hussein,
E.K.Duff,
and
C.Sirard
(2003).
Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2.
|
| |
J Biol Chem, 278,
48805-48814.
|
 |
|
|
|
|
 |
Y.Shi,
and
J.Massagué
(2003).
Mechanisms of TGF-beta signaling from cell membrane to the nucleus.
|
| |
Cell, 113,
685-700.
|
 |
|
|
|
|
 |
Z.Xiao,
A.M.Brownawell,
I.G.Macara,
and
H.F.Lodish
(2003).
A novel nuclear export signal in Smad1 is essential for its signaling activity.
|
| |
J Biol Chem, 278,
34245-34252.
|
 |
|
|
|
|
 |
A.Blokzijl,
P.ten Dijke,
and
C.F.Ibáñez
(2002).
Physical and functional interaction between GATA-3 and Smad3 allows TGF-beta regulation of GATA target genes.
|
| |
Curr Biol, 12,
35-45.
|
 |
|
|
|
|
 |
A.Mehra,
and
J.L.Wrana
(2002).
TGF-beta and the Smad signal transduction pathway.
|
| |
Biochem Cell Biol, 80,
605-622.
|
 |
|
|
|
|
 |
C.W.Jang,
C.H.Chen,
C.C.Chen,
J.Y.Chen,
Y.H.Su,
and
R.H.Chen
(2002).
TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase.
|
| |
Nat Cell Biol, 4,
51-58.
|
 |
|
|
|
|
 |
D.K.Lee,
B.C.Kim,
J.N.Brady,
K.T.Jeang,
and
S.J.Kim
(2002).
Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element.
|
| |
J Biol Chem, 277,
33766-33775.
|
 |
|
|
|
|
 |
D.U.Kloos,
C.Choi,
and
E.Wingender
(2002).
The TGF-beta--Smad network: introducing bioinformatic tools.
|
| |
Trends Genet, 18,
96.
|
 |
|
|
|
|
 |
F.Verrecchia,
and
A.Mauviel
(2002).
Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.
|
| |
J Invest Dermatol, 118,
211-215.
|
 |
|
|
|
|
 |
F.Verrecchia,
E.F.Wagner,
and
A.Mauviel
(2002).
Distinct involvement of the Jun-N-terminal kinase and NF-kappaB pathways in the repression of the human COL1A2 gene by TNF-alpha.
|
| |
EMBO Rep, 3,
1069-1074.
|
 |
|
|
|
|
 |
G.J.Inman,
and
C.S.Hill
(2002).
Stoichiometry of active smad-transcription factor complexes on DNA.
|
| |
J Biol Chem, 277,
51008-51016.
|
 |
|
|
|
|
 |
G.T.Park,
and
M.I.Morasso
(2002).
Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes.
|
| |
Nucleic Acids Res, 30,
515-522.
|
 |
|
|
|
|
 |
H.Jono,
T.Shuto,
H.Xu,
H.Kai,
D.J.Lim,
J.R.Gum,
Y.S.Kim,
S.Yamaoka,
X.H.Feng,
and
J.D.Li
(2002).
Transforming growth factor-beta -Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription.
|
| |
J Biol Chem, 277,
45547-45557.
|
 |
|
|
|
|
 |
J.L.Vivian,
Y.Chen,
D.Yee,
E.Schneider,
and
T.Magnuson
(2002).
An allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N- nitrosourea-mutagenized mouse embryonic stem cells.
|
| |
Proc Natl Acad Sci U S A, 99,
15542-15547.
|
 |
|
|
|
|
 |
J.W.Wu,
A.R.Krawitz,
J.Chai,
W.Li,
F.Zhang,
K.Luo,
and
Y.Shi
(2002).
Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling.
|
| |
Cell, 111,
357-367.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.K.Hirschi,
L.Lai,
N.S.Belaguli,
D.A.Dean,
R.J.Schwartz,
and
W.E.Zimmer
(2002).
Transforming growth factor-beta induction of smooth muscle cell phenotpye requires transcriptional and post-transcriptional control of serum response factor.
|
| |
J Biol Chem, 277,
6287-6295.
|
 |
|
|
|
|
 |
L.Zawel,
J.Yu,
C.J.Torrance,
S.Markowitz,
K.W.Kinzler,
B.Vogelstein,
and
S.Zhou
(2002).
DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activities.
|
| |
Proc Natl Acad Sci U S A, 99,
2848-2853.
|
 |
|
|
|
|
 |
O.Korchynskyi,
and
P.ten Dijke
(2002).
Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter.
|
| |
J Biol Chem, 277,
4883-4891.
|
 |
|
|
|
|
 |
P.Ten Dijke,
M.J.Goumans,
F.Itoh,
and
S.Itoh
(2002).
Regulation of cell proliferation by Smad proteins.
|
| |
J Cell Physiol, 191,
1.
|
 |
|
|
|
|
 |
S.Shim,
N.Bae,
and
J.K.Han
(2002).
Bone morphogenetic protein-4-induced activation of Xretpos is mediated by Smads and Olf-1/EBF associated zinc finger (OAZ).
|
| |
Nucleic Acids Res, 30,
3107-3117.
|
 |
|
|
|
|
 |
T.Katagiri,
M.Imada,
T.Yanai,
T.Suda,
N.Takahashi,
and
R.Kamijo
(2002).
Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis.
|
| |
Genes Cells, 7,
949-960.
|
 |
|
|
|
|
 |
T.L.McGaha,
R.G.Phelps,
H.Spiera,
and
C.Bona
(2002).
Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.
|
| |
J Invest Dermatol, 118,
461-470.
|
 |
|
|
|
|
 |
W.Zhang,
T.A.Yatskievych,
X.Cao,
and
P.B.Antin
(2002).
Regulation of Hex gene expression by a Smads-dependent signaling pathway.
|
| |
J Biol Chem, 277,
45435-45441.
|
 |
|
|
|
|
 |
Z.J.Shen,
T.Nakamoto,
K.Tsuji,
A.Nifuji,
K.Miyazono,
T.Komori,
H.Hirai,
and
M.Noda
(2002).
Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts.
|
| |
J Biol Chem, 277,
29840-29846.
|
 |
|
|
|
|
 |
A.Kurisaki,
S.Kose,
Y.Yoneda,
C.H.Heldin,
and
A.Moustakas
(2001).
Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner.
|
| |
Mol Biol Cell, 12,
1079-1091.
|
 |
|
|
|
|
 |
C.Rushlow,
P.F.Colosimo,
M.C.Lin,
M.Xu,
and
N.Kirov
(2001).
Transcriptional regulation of the Drosophila gene zen by competing Smad and Brinker inputs.
|
| |
Genes Dev, 15,
340-351.
|
 |
|
|
|
|
 |
D.Maurice,
C.E.Pierreux,
M.Howell,
R.E.Wilentz,
M.J.Owen,
and
C.S.Hill
(2001).
Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability.
|
| |
J Biol Chem, 276,
43175-43181.
|
 |
|
|
|
|
 |
G.Farmer,
E.S.Connolly,
J.Mocco,
and
L.P.Freedman
(2001).
Molecular analysis of the prostate-specific antigen upstream gene enhancer.
|
| |
Prostate, 46,
76-85.
|
 |
|
|
|
|
 |
G.Samuel,
D.Miller,
and
R.Saint
(2001).
Conservation of a DPP/BMP signaling pathway in the nonbilateral cnidarian Acropora millepora.
|
| |
Evol Dev, 3,
241-250.
|
 |
|
|
|
|
 |
J.Yue,
and
K.M.Mulder
(2001).
Transforming growth factor-beta signal transduction in epithelial cells.
|
| |
Pharmacol Ther, 91,
1.
|
 |
|
|
|
|
 |
L.Attisano,
and
S.Tuen Lee-Hoeflich
(2001).
The Smads.
|
| |
Genome Biol, 2,
REVIEWS3010.
|
 |
|
|
|
|
 |
N.V.Grishin
(2001).
Treble clef finger--a functionally diverse zinc-binding structural motif.
|
| |
Nucleic Acids Res, 29,
1703-1714.
|
 |
|
|
|
|
 |
R.M.Marquez,
M.A.Singer,
N.T.Takaesu,
W.R.Waldrip,
Y.Kraytsberg,
and
S.J.Newfeld
(2001).
Transgenic analysis of the Smad family of TGF-beta signal transducers in Drosophila melanogaster suggests new roles and new interactions between family members.
|
| |
Genetics, 157,
1639-1648.
|
 |
|
|
|
|
 |
T.Sánchez-Elsner,
L.M.Botella,
B.Velasco,
A.Corbí,
L.Attisano,
and
C.Bernabéu
(2001).
Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression.
|
| |
J Biol Chem, 276,
38527-38535.
|
 |
|
|
|
|
 |
Y.Shi
(2001).
Structural insights on Smad function in TGFbeta signaling.
|
| |
Bioessays, 23,
223-232.
|
 |
|
|
|
|
 |
Z.A.Quinn,
C.C.Yang,
J.L.Wrana,
and
J.C.McDermott
(2001).
Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins.
|
| |
Nucleic Acids Res, 29,
732-742.
|
 |
|
|
|
|
 |
A.Hata,
J.Seoane,
G.Lagna,
E.Montalvo,
A.Hemmati-Brivanlou,
and
J.Massagué
(2000).
OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways.
|
| |
Cell, 100,
229-240.
|
 |
|
|
|
|
 |
E.Pardali,
X.Q.Xie,
P.Tsapogas,
S.Itoh,
K.Arvanitidis,
C.H.Heldin,
P.ten Dijke,
T.Grundström,
and
P.Sideras
(2000).
Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes.
|
| |
J Biol Chem, 275,
3552-3560.
|
 |
|
|
|
|
 |
J.B.Jones,
and
S.E.Kern
(2000).
Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4.
|
| |
Nucleic Acids Res, 28,
2363-2368.
|
 |
|
|
|
|
 |
J.L.Riechmann,
J.Heard,
G.Martin,
L.Reuber,
C.Jiang,
J.Keddie,
L.Adam,
O.Pineda,
O.J.Ratcliffe,
R.R.Samaha,
R.Creelman,
M.Pilgrim,
P.Broun,
J.Z.Zhang,
D.Ghandehari,
B.K.Sherman,
and
G.Yu
(2000).
Arabidopsis transcription factors: genome-wide comparative analysis among eukaryotes.
|
| |
Science, 290,
2105-2110.
|
 |
|
|
|
|
 |
J.L.Wrana,
and
L.Attisano
(2000).
The Smad pathway.
|
| |
Cytokine Growth Factor Rev, 11,
5.
|
 |
|
|
|
|
 |
J.Massagué,
and
D.Wotton
(2000).
Transcriptional control by the TGF-beta/Smad signaling system.
|
| |
EMBO J, 19,
1745-1754.
|
 |
|
|
|
|
 |
J.Massagué,
S.W.Blain,
and
R.S.Lo
(2000).
TGFbeta signaling in growth control, cancer, and heritable disorders.
|
| |
Cell, 103,
295-309.
|
 |
|
|
|
|
 |
J.Xu,
and
L.Attisano
(2000).
Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
|
| |
Proc Natl Acad Sci U S A, 97,
4820-4825.
|
 |
|
|
|
|
 |
K.Kusanagi,
H.Inoue,
Y.Ishidou,
H.K.Mishima,
M.Kawabata,
and
K.Miyazono
(2000).
Characterization of a bone morphogenetic protein-responsive Smad-binding element.
|
| |
Mol Biol Cell, 11,
555-565.
|
 |
|
|
|
|
 |
L.Attisano,
and
J.L.Wrana
(2000).
Smads as transcriptional co-modulators.
|
| |
Curr Opin Cell Biol, 12,
235-243.
|
 |
|
|
|
|
 |
M.P.de Caestecker,
T.Yahata,
D.Wang,
W.T.Parks,
S.Huang,
C.S.Hill,
T.Shioda,
A.B.Roberts,
and
R.J.Lechleider
(2000).
The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain.
|
| |
J Biol Chem, 275,
2115-2122.
|
 |
|
|
|
|
 |
N.G.Denissova,
C.Pouponnot,
J.Long,
D.He,
and
F.Liu
(2000).
Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter.
|
| |
Proc Natl Acad Sci U S A, 97,
6397-6402.
|
 |
|
|
|
|
 |
S.Bai,
X.Shi,
X.Yang,
and
X.Cao
(2000).
Smad6 as a transcriptional corepressor.
|
| |
J Biol Chem, 275,
8267-8270.
|
 |
|
|
|
|
 |
S.Germain,
M.Howell,
G.M.Esslemont,
and
C.S.Hill
(2000).
Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif.
|
| |
Genes Dev, 14,
435-451.
|
 |
|
|
|
|
 |
S.Itoh,
F.Itoh,
M.J.Goumans,
and
P.Ten Dijke
(2000).
Signaling of transforming growth factor-beta family members through Smad proteins.
|
| |
Eur J Biochem, 267,
6954-6967.
|
 |
|
|
|
|
 |
S.J.Chen,
W.Yuan,
S.Lo,
M.Trojanowska,
and
J.Varga
(2000).
Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
|
| |
J Cell Physiol, 183,
381-392.
|
 |
|
|
|
|
 |
S.J.Wicks,
S.Lui,
N.Abdel-Wahab,
R.M.Mason,
and
A.Chantry
(2000).
Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.
|
| |
Mol Cell Biol, 20,
8103-8111.
|
 |
|
|
|
|
 |
X.H.Feng,
X.Lin,
and
R.Derynck
(2000).
Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
|
| |
EMBO J, 19,
5178-5193.
|
 |
|
|
|
|
 |
X.Yang,
X.Ji,
X.Shi,
and
X.Cao
(2000).
Smad1 domains interacting with Hoxc-8 induce osteoblast differentiation.
|
| |
J Biol Chem, 275,
1065-1072.
|
 |
|
|
|
|
 |
Z.Xiao,
X.Liu,
Y.I.Henis,
and
H.F.Lodish
(2000).
A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation.
|
| |
Proc Natl Acad Sci U S A, 97,
7853-7858.
|
 |
|
|
|
|
 |
A.Jaźwińska,
N.Kirov,
E.Wieschaus,
S.Roth,
and
C.Rushlow
(1999).
The Drosophila gene brinker reveals a novel mechanism of Dpp target gene regulation.
|
| |
Cell, 96,
563-573.
|
 |
|
|
|
|
 |
C.S.Hill
(1999).
The Smads.
|
| |
Int J Biochem Cell Biol, 31,
1249-1254.
|
 |
|
|
|
|
 |
C.Wong,
E.M.Rougier-Chapman,
J.P.Frederick,
M.B.Datto,
N.T.Liberati,
J.M.Li,
and
X.F.Wang
(1999).
Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta.
|
| |
Mol Cell Biol, 19,
1821-1830.
|
 |
|
|
|
|
 |
D.Wotton,
R.S.Lo,
S.Lee,
and
J.Massagué
(1999).
A Smad transcriptional corepressor.
|
| |
Cell, 97,
29-39.
|
 |
|
|
|
|
 |
J.B.Hoying,
M.Yin,
R.Diebold,
I.Ormsby,
A.Becker,
and
T.Doetschman
(1999).
Transforming growth factor beta1 enhances platelet aggregation through a non-transcriptional effect on the fibrinogen receptor.
|
| |
J Biol Chem, 274,
31008-31013.
|
 |
|
|
|
|
 |
J.Heyer,
D.Escalante-Alcalde,
M.Lia,
E.Boettinger,
W.Edelmann,
C.L.Stewart,
and
R.Kucherlapati
(1999).
Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis.
|
| |
Proc Natl Acad Sci U S A, 96,
12595-12600.
|
 |
|
|
|
|
 |
J.L.Dai,
M.Schutte,
R.K.Bansal,
R.E.Wilentz,
A.Y.Sugar,
and
S.E.Kern
(1999).
Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells.
|
| |
Mol Carcinog, 26,
37-43.
|
 |
|
|
|
|
 |
K.Johnson,
H.Kirkpatrick,
A.Comer,
F.M.Hoffmann,
and
A.Laughon
(1999).
Interaction of Smad complexes with tripartite DNA-binding sites.
|
| |
J Biol Chem, 274,
20709-20716.
|
 |
|
|
|
|
 |
K.L.Pearson,
T.Hunter,
and
R.Janknecht
(1999).
Activation of Smad1-mediated transcription by p300/CBP.
|
| |
Biochim Biophys Acta, 1489,
354-364.
|
 |
|
|
|
|
 |
K.Luo,
S.L.Stroschein,
W.Wang,
D.Chen,
E.Martens,
S.Zhou,
and
Q.Zhou
(1999).
The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling.
|
| |
Genes Dev, 13,
2196-2206.
|
 |
|
|
|
|
 |
K.Nakashima,
M.Yanagisawa,
H.Arakawa,
N.Kimura,
T.Hisatsune,
M.Kawabata,
K.Miyazono,
and
T.Taga
(1999).
Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300.
|
| |
Science, 284,
479-482.
|
 |
|
|
|
|
 |
K.Tada,
H.Inoue,
T.Ebisawa,
M.Makuuchi,
M.Kawabata,
T.Imamura,
and
K.Miyazono
(1999).
Region between alpha-helices 3 and 4 of the mad homology 2 domain of Smad4: functional roles in oligomer formation and transcriptional activation.
|
| |
Genes Cells, 4,
731-741.
|
 |
|
|
|
|
 |
K.Verschueren,
and
D.Huylebroeck
(1999).
Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells.
|
| |
Cytokine Growth Factor Rev, 10,
187-199.
|
 |
|
|
|
|
 |
L.Chen
(1999).
Combinatorial gene regulation by eukaryotic transcription factors.
|
| |
Curr Opin Struct Biol, 9,
48-55.
|
 |
|
|
|
|
 |
M.B.Datto,
J.P.Frederick,
L.Pan,
A.J.Borton,
Y.Zhuang,
and
X.F.Wang
(1999).
Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction.
|
| |
Mol Cell Biol, 19,
2495-2504.
|
 |
|
|
|
|
 |
M.Kretzschmar,
J.Doody,
I.Timokhina,
and
J.Massagué
(1999).
A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.
|
| |
Genes Dev, 13,
804-816.
|
 |
|
|
|
|
 |
P.Das,
H.Inoue,
J.C.Baker,
H.Beppu,
M.Kawabata,
R.M.Harland,
K.Miyazono,
and
R.W.Padgett
(1999).
Drosophila dSmad2 and Atr-I transmit activin/TGFbeta signals.
|
| |
Genes Cells, 4,
123-134.
|
 |
|
|
|
|
 |
P.J.Kilshaw
(1999).
Alpha E beta 7.
|
| |
Mol Pathol, 52,
203-207.
|
 |
|
|
|
|
 |
R.P.Nagarajan,
J.Liu,
and
Y.Chen
(1999).
Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
|
| |
J Biol Chem, 274,
31229-31235.
|
 |
|
|
|
|
 |
S.L.Stroschein,
W.Wang,
and
K.Luo
(1999).
Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation.
|
| |
J Biol Chem, 274,
9431-9441.
|
 |
|
|
|
|
 |
S.L.Stroschein,
W.Wang,
S.Zhou,
Q.Zhou,
and
K.Luo
(1999).
Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.
|
| |
Science, 286,
771-774.
|
 |
|
|
|
|
 |
X.Hua,
Z.A.Miller,
G.Wu,
Y.Shi,
and
H.F.Lodish
(1999).
Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins.
|
| |
Proc Natl Acad Sci U S A, 96,
13130-13135.
|
 |
|
|
|
|
 |
Y.Zhang,
and
R.Derynck
(1999).
Regulation of Smad signalling by protein associations and signalling crosstalk.
|
| |
Trends Cell Biol, 9,
274-279.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|